Case File
efta-01932167DOJ Data Set 10OtherEFTA01932167
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01932167
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
jeevacation©gmail.com[jeevacation©gmail.com]
From:
Ada Clapp
Sent
Mon 3/3/2014 4:31:21 PM
Subject: FW: Art Use Agreements-Debra Black
Hi Jeffrey—have you now had a chance to review the Art Use Agreements? Do you want me to resend
them for convenience?
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Tuesday, February 18, 2014 1:55 PM
To: Ada Clapp
Subject: Re: Art Use Agreements-Debra Black
wait until i can review in depth, see you thurs please
On Tue, Feb 18, 2014 at 6:54 PM, Ada Clapp c
wrote:
Hi Jeffrey,
I was about to send these out for signature with the 1997 Trust decanting documents—did
you want to sign off on them first? They arc the art use agreements for Debra to use the art
held in the APOI and APO2 Trusts. Please let me know.
Best,
Ada Clapp
Elysium Management LLC
445 Park Avenue
Suite 1401
New York, New York 10022
Direct Dial:
EFTA_R1_00384080
EFTA01932167
Fax:
Email:
IRS Circular 230 Disclosure: Pursuant to IRS regulations, I inform you that any tax advice
contained in this communication (including attachments) is not intended or written to be used,
and cannot be used, by any person or entity for the purposes of (i) avoiding tax related
penalties imposed by any governmental tax authority, or (ii) proposing, marketing or
recommending to another party any transaction or matter discussed herein. I advise you to
consult with an independent tax advisor on your particular tax circumstances.
This communication and any attachment is for the intended recipient(s) only and may
contain information that is privileged, confidential and/or proprietary. If you are not the
intended recipient, you are hereby notified that further dissemination of this communication
and its attachments is prohibited. Please delete all copies of this communication and its
attachments and notify me immediately that you have received them in error. Thank you.
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return c-mail or by c-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00384081
EFTA01932168
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.